Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study

Abstract

Background/Aims: Opportunistic infection in inflammatory bowel disease (IBD) has become a serious problem. However, its status of doctors' opinions and test equipment in hospitals are unclear. The aim of the study was to investigate these issues to improve the prognosis of IBD patients.Methods: This retrospective, multicenter study was conducted by 83 investigators who were members of the Asian Organization for Crohn's and Colitis. Data on opportunistic infection were collected from hospital databases between January 2017 and December 2017. The survey consisted of 11 items.Results: Most physicians appreciated the diagnostic value of tissue cytomegalovirus (CMV) DNA, accounting for 86.1% of members in China, 37.5% in Japan, 52.9% in South Korea, and 66.7% in Southeast Asia. Only 83.1% of hos pitals had the ability to test for CMV immunohistochemistry in Asia. Hepatitis B surface antigen (HBsAg) screening was recommended by all members. However, only 66.7% in China, 70.6% in South Korea, and 66.7% in Southeast Asia agreed to routinely vaccinate IBD patients when HBsAg tested negative. Most members preferred metronidazole (74.7%) as the first choice for patients with Clostridium difficile infection. However, the proportion of stool C. difficile toxin test was lower in China than in other areas (75.0% in China vs 95.8% in Japan and 100% in South Korea and Southeast Asia, p<0.05). Conclusions: Opportunistic infection from CMV, hepatitis B virus, and C. difficile should be of high concern for IBD patients. More efforts are needed, such as understanding consensus in clinical practice and improving testing facilities in hospitals. (Gut Liver 2022;16:726-735

Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

“…This online questionnaire survey recruited a large number of Asian physicians, more than half of whom were gastroenterologists specializing in IBD, suggesting that the survey findings reflect real-world clinical settings in these Asian countries/regions. Moreover, in contrast to a previous study based on questionnaires administered to IBD investigators [ 48 ], the present study included a large number of Asian physicians from various countries. This present finding may also offer insights into the management of infectious complications in Asian patients with IBD that are distinct from those observed in Western patients with IBD [ 49 , 50 ].…”

Risk Factors of Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study

“…However, frequent, long-term, and combined use of immunosuppressive agents can lead to critical clinical issues, such as opportunistic infections, in IBD patients. 3 , 8 - 12 …”

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries

“…In a previous study, Yang et al [ 8 ] also investigated infectious complications in Asian patients with IBD using a questionnaire survey. They found that most physicians considered tissue cytomegalovirus (CMV) DNA as an index for the diagnosis of CMV colitis.…”